Medical device and MedTech insights, news, tips and more

Smith & Nephew Discussing $3B NuVasive Acquisition

February 11, 2019

s&n nuvasive

Smith & Nephew is in discussions to pick up spine-focused medtech developer NuVasive Inc. in a deal that could be worth more than $3 billion, according to a report from the Financial Times released late last week.

The companies have not officially commented on the possible acquisition.

NuVasive has a market valuation of approximately $2.6 billion, according to a Reuters report, with the alleged deal expecting to exceed the $3 billion threshold.

The acquisition could be a way for U.K.-based Smith & Nephew to improve its margins and find new growth to improve its position as compared to its larger rivals in the field, according to the Reuters report.

But exact terms of the deal “could not be learned” and the talks “may fall apart,” according to the Financial Times report, leaving the deal in a speculative state.

The timing of the deal is “surprising”, according to SVB Leerink market analyst Richard Newitter, as NuVasive just named former Medtronic surgical innovations prez J. Barry its new CEO last November, leaving the company without enough time to progress towards a ‘turnaround’.

“All of this may be very preliminary and/or amount to nothing more than speculation,” Newitter wrote in a letter to investors.

The acquisition rumor comes as NuVasive share prices neared their 52-week low, according to Newitter, who commented that “investors are braced for things to get worse at [Nuvasive] before they get better.”

Whether or not the acquisition is unlikely, Newitter said that NuVasive’s spinal portfolio could complement Smith & Nephew’s existing orthopedic offerings, but noted that potential synergies “would likely have to stem from a cross-selling thesis.”

See Full Article at the Source: Report: Smith & Nephew eyeing $3B NuVasive acquisition – MassDevice

Article Written by Fink Densford

A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.


More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.